With a new online resource, Eisai is offering patients and caregivers some direction to help navigate a kidney cancer ...

Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...

Dr. Eric Singer reveals the latest advances in kidney cancer care that help patients live longer and maintain quality of life.

Earlier analyses demonstrated strong local tumor control, with nearly nine in 10 patients remaining free of recurrence at ...

Kidney cancer is a growing, serious, and potentially fatal health problem globally. According to the American Cancer Society's 2023 projections, 81,800 new cases (52,360 in men and 29,440 in women) ...

The treatment landscape for clear cell renal cell carcinoma (ccRCC) could be due for a shake-up following dual breakthroughs ...

The Rising Threat of Kidney Cancer Kidney cancer is increasingly recognized as a serious and potentially life-threatening condition worldwide. The American Cancer Society's projections for 2023 ...

Many medicines are available to treat kidney cancer. If one treatment doesn’t help or stops working, your health care provider may recommend another option. If you or a loved one has kidney cancer and ...

An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict which kidney cancer patients will benefit from anti-angiogenic therapy, a ...

Forget one-size-fits-all cancer treatments — personalization is the future, and it’s already showing promise. In a groundbreaking early-phase trial, a personalized vaccine triggered a powerful immune ...

Most people with kidney cancer first come to Fred Hutch after being diagnosed by another physician, often their primary care physician. We confirm this diagnosis and other details about your disease ...